Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Rev Pneumol Clin ; 69(5): 291-3, 2013 Oct.
Artículo en Francés | MEDLINE | ID: mdl-23796498

RESUMEN

Malignant mesothelioma is a relatively uncommon malignancy. Although the pathogenesis is primarily related to asbestos, the role of ionizing radiation is more controversial. We report the case of a 41-year-old male who developed pleural mesothelioma. He had both, a prior short asbestos exposure and a thoracic radiotherapy for Hodgkin's disease 26years before. The evidence for radiotherapy as cause for mesothelioma is expanding and the diagnosis of mesothelioma in patients who had previous irradiation should be kept in mind.


Asunto(s)
Enfermedad de Hodgkin/radioterapia , Neoplasias Pulmonares/diagnóstico , Mesotelioma/diagnóstico , Neoplasias Inducidas por Radiación/diagnóstico , Neoplasias Pleurales/diagnóstico , Adulto , Humanos , Neoplasias Pulmonares/etiología , Masculino , Mesotelioma/etiología , Mesotelioma Maligno , Neoplasias Pleurales/etiología , Pleuresia/etiología , Radiografía Torácica
3.
Rev Pneumol Clin ; 67(3): 167-9, 2011 Jun.
Artículo en Francés | MEDLINE | ID: mdl-21665081

RESUMEN

Acquired eosinophilia is currently classified into secondary (reactional to underlying diseases), clonal (presence of a bone marrow histological, cytogenetic or molecular marker of a myeloid malignancy) and idiopathic (neither secondary nor clonal) categories. We report the case of a 47-year-old male who was admitted to the hospital for Staphylococcus aureus recurring infections. An hypereosinophilia was discovered and led to molecular analysis. The identification of FIP1L1-PDGFRA fusion gene permitted the diagnostic of clonal eosinophilia. Treatment by imatinib mesylate induced an haematological remission, the control of the infection and thoracotomy cicatrization. This case is original because of its infectious presentation and the efficacy of imatinib mesylate to control the infectious process.


Asunto(s)
Eosinofilia/diagnóstico , Eosinofilia/microbiología , Piperazinas/uso terapéutico , Inhibidores de Proteínas Quinasas/uso terapéutico , Pirimidinas/uso terapéutico , Infecciones Estafilocócicas/complicaciones , Staphylococcus aureus , Antibacterianos/uso terapéutico , Benzamidas , Biomarcadores/metabolismo , Células Clonales/patología , Eosinofilia/tratamiento farmacológico , Eosinofilia/genética , Reordenamiento Génico , Humanos , Mesilato de Imatinib , Masculino , Persona de Mediana Edad , Receptor alfa de Factor de Crecimiento Derivado de Plaquetas/genética , Recurrencia , Factores de Riesgo , Fumar/efectos adversos , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/aislamiento & purificación , Resultado del Tratamiento , Factores de Escisión y Poliadenilación de ARNm/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...